Da-Wei Wang (Dawei Wang)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Top Venues

Nature biotechnology

Thrombosis and haemostasis

Nature biomedical engineering

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Da-Wei Wang, Xiaohu Shao, Qiang Wang, Xiaohong Pan, Yu-Jun Dai, Shuxian Yao, Tong Yin, Zhugang Wang, Jiang Zhu, Xiaodong Xi, Zhu Chen, Saijuan Chen, Guowei Zhang
Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B. Clinical and translational medicine 11 (3) (2022)
Yun Wang, Jianhua Mao, Li Li, Bing Xiao, Zheng Ruan, Yichen Liu, Guowei Zhang, Da-Wei Wang, Jian-Qing Mi, Chao Fang, Xiaodong Xi, Xiaofeng Shi, Jin Wang
Characteristics of the Thrombus Formation in Transgenic Mice with Platelet-Targeted Factor VIII Expression. Thrombosis and haemostasis (2021)
Yu-Jun Dai, Si-Yuan He, Fang Hu, Xue-Ping Li, Jian-Ming Zhang, Si-Liang Chen, Wei-Na Zhang, Hai-Min Sun, Da-Wei Wang
Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia. Molecular cancer 20 (1) (2021)
Di Yin, Sikai Ling, Da-Wei Wang, Yao Dai, Hao Jiang, Xujiao Zhou, Soren Riis Paludan, Jiaxu Hong, Yujia Cai
Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice. Nature biotechnology 39 (5) (2021)
Binbin Li, Zhihan Wu, Wenjue Xu, Wenwen Han, Jiayu Liu, Da-Wei Wang, Guowei Zhang
Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua. Human gene therapy 32 (9-10) (2021)
Sikai Ling, Shiqi Yang, Xinde Hu, Di Yin, Yao Dai, Xiaoqing Qian, Da-Wei Wang, Xiaoyong Pan, Jiaxu Hong, Xiaodong Sun, Hui Yang, Soren Riis Paludan, Yujia Cai
Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nature biomedical engineering 5 (2) (2021)